Other equities research analysts also recently issued research reports about the company. UBS Group set a €27.00 ($33.33) price target on Evonik Industries and gave the company a sell rating in a research report on Thursday, December 7th. Credit Suisse Group set a €34.30 ($42.35) price objective on Evonik Industries and gave the stock a buy rating in a report on Wednesday. Warburg Research set a €38.70 ($47.78) price objective on Evonik Industries and gave the stock a buy rating in a report on Wednesday, January 10th. Baader Bank set a €38.00 ($46.91) price objective on Evonik Industries and gave the stock a buy rating in a report on Tuesday, February 6th. Finally, Deutsche Bank set a €40.00 ($49.38) price objective on Evonik Industries and gave the stock a buy rating in a report on Monday, December 4th. Three research analysts have rated the stock with a sell rating, five have issued a hold rating and twelve have issued a buy rating to the company’s stock. The company currently has a consensus rating of Hold and a consensus price target of €33.79 ($41.72).
Shares of Evonik Industries (FRA:EVK) opened at €28.84 ($35.60) on Thursday. Evonik Industries has a 12-month low of €26.78 ($33.06) and a 12-month high of €32.97 ($40.70). The firm has a market capitalization of $13,430.00 and a PE ratio of 18.73.
COPYRIGHT VIOLATION WARNING: This report was first reported by Ticker Report and is the sole property of of Ticker Report. If you are reading this report on another publication, it was illegally copied and reposted in violation of United States and international copyright laws. The original version of this report can be viewed at https://www.tickerreport.com/banking-finance/3254982/evonik-industries-evk-given-a-37-00-price-target-by-berenberg-bank-analysts.html.
Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemical quaternary derivatives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, animal nutrition, and healthcare sectors.
Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.